{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:12:11Z","timestamp":1777975931923,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ogla.2020.02.006","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T02:10:25Z","timestamp":1582942225000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and Efficacy of 0.1% Nepafenac versus 1% Prednisolone Acetate Eye Drops after Laser Peripheral Iridotomy"],"prefix":"10.1016","volume":"3","author":[{"given":"Keerthi","family":"Gayam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep Y.","family":"Ramulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh","family":"Rengaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavitha","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2020.02.006_bib1","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/bjophthalmol-2014-306557","article-title":"Steroid-induced glaucoma and childhood blindness","volume":"99","author":"Gupta","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2020.02.006_bib2","first-page":"187","article-title":"Statistical attributes of the steroid hypertensive response in the clinically normal eye. 1. The demonstration of three levels of response","volume":"14","author":"Armaly","year":"1965","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2020.02.006_bib3","first-page":"198","article-title":"Intraocular pressure response to topical corticosteroids","volume":"4","author":"Becker","year":"1965","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.ogla.2020.02.006_bib4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.86.12.1380","article-title":"Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery","volume":"86","author":"Laurell","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2020.02.006_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bjo.81.4.299","article-title":"Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery","volume":"81","author":"Wright","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2020.02.006_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4103\/0301-4738.129781","article-title":"Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy","volume":"62","author":"Nagpal","year":"2014","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ogla.2020.02.006_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1007001131987","article-title":"Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In\u00a0vitro bioactivation and permeation of external ocular barriers","volume":"24","author":"Ke","year":"2000","journal-title":"Inflammation"},{"key":"10.1016\/j.ogla.2020.02.006_bib8","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0161-6420(00)00360-2","article-title":"Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy","volume":"107","author":"Ang","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2020.02.006_bib9","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2006.02.016","article-title":"Long-term outcomes in fellow eyes after acute primary angle closure in the contralateral eye","volume":"113","author":"Friedman","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2020.02.006_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/bjo.46.11.641","article-title":"Acute angle-closure glaucoma: the second eye: an analysis of 200 cases","volume":"46","author":"Lowe","year":"1962","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2020.02.006_bib11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.ophtha.2015.04.015","article-title":"Use of various glaucoma surgeries and procedures in the Medicare beneficiaries from 1994\u20132012","volume":"122","author":"Arora","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2020.02.006_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjo.86.2.238","article-title":"The definition and classification of glaucoma in prevalence surveys","volume":"86","author":"Foster","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ogla.2020.02.006_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2020.02.006_bib14","first-page":"97","article-title":"Management of ocular inflammation following routine cataract surgery-topical corticosteroid (prednisolone) versus topical non-steroidal (bromfenac)","volume":"4","author":"Walter","year":"2011","journal-title":"Us Ophthalmic Review"},{"key":"10.1016\/j.ogla.2020.02.006_bib15","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jcrs.2011.03.052","article-title":"Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery","volume":"37","author":"Miyake","year":"2011","journal-title":"J\u00a0Cataract Refract Surg"},{"issue":"11","key":"10.1016\/j.ogla.2020.02.006_bib16","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.ophtha.2019.05.032","article-title":"SALT Trial: steroids after laser trabeculoplasty: impact of short-term anti-inflammatory treatment on selective laser trabeculoplasty efficacy","volume":"126","author":"Groth","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2020.02.006_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9394(70)92463-3","article-title":"Uveitis in association with topically administered corticosteroid","volume":"3","author":"Krupin","year":"1970","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2020.02.006_bib18","author":"Ismail"},{"issue":"2","key":"10.1016\/j.ogla.2020.02.006_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","article-title":"Steroid-induced glaucoma: an avoidable irreversible blindness","volume":"11","author":"Phulke","year":"2017","journal-title":"J\u00a0Curr Glaucoma Pract"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258941962030051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258941962030051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:51:28Z","timestamp":1762887088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258941962030051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S258941962030051X"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2020.02.006","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of 0.1% Nepafenac versus 1% Prednisolone Acetate Eye Drops after Laser Peripheral Iridotomy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2020.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}